申请人:KabiVitrum AB
公开号:US04483867A1
公开(公告)日:1984-11-20
Novel antifibrinolytically active compounds of the formula ##STR1## and therapeutically acceptable salt thereof, wherein R.sup.1 is selected from the group consisting of (a) alkyl groups containing 1-4 carbon atoms, (b) alkoxy groups containing 1-4 carbon atoms, ##STR2## R.sup.2 is selected from the group consisting of (a) H, (b) alkyl groups containing 1-4 carbon atoms, (c) --COOR.sup.3, wherein R.sup.3 is an alkyl group containing 1-4 carbon atoms, (d) --CONR.sup.4 R.sup.5, wherein R.sup.4 and R.sup.5 are the same or different alkyl groups containing 1-3 carbon atoms; or wherein R.sup.1 and R.sup.2 represent together the radical ##STR3##
化合物的新型抗纤溶活性化合物的结构式为##STR1##及其治疗上可接受的盐,其中R.sup.1选自以下组:(a)含有1-4个碳原子的烷基基团,(b)含有1-4个碳原子的烷氧基团,##STR2##R.sup.2选自以下组:(a)H,(b)含有1-4个碳原子的烷基基团,(c)--COOR.sup.3,其中R.sup.3是含有1-4个碳原子的烷基基团,(d)--CONR.sup.4 R.sup.5,其中R.sup.4和R.sup.5是相同或不同的含有1-3个碳原子的烷基基团;或其中R.sup.1和R.sup.2共同表示如下基团##STR3##